Sepsisprävention nach Splenektomie

Schlüsselwörter

Splenektomie - Sepsis - Pneumokokken - Prävention - Impfungen

Keywords

splenectomy - sepsis - pneumococcus - prevention - vaccination

• Literatur

• 1 Berner R, Müller C, Belard S. Epidemiologie und Therapie invasiver Meningokokken-Infektionen. Klin Padiatr 2010; 222: HV_40
• 2 Bisharat N, Omari H, Lavi I et al. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43: 182-186
• 3 Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61: 816-819
• 4 Cherif H, Landgren O, Konradsen HB et al. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006; 24: 75-81
• 5 Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA 2013; 309: 275-282
• 6 Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
• 7 Dendle C, Sundararajan V, Spelman T et al. Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria. Med J Aust 2012; 196: 582-586
• 8 Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet 2011; 378: 86-97
• 9 Ejstrud P, Kristensen B, Hansen JB et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis 2000; 32: 521-525
• 10 Engelhardt M, Eber SW, Germing U et al. Prävention von Infektionen und Thrombosen nach Splenektomie oder funktioneller Asplenie. http://www.dgho-onkopedia.de/de/onkopedia/leitlinien/praevention-von-infektionen-und-thrombosen-nach . Letzter Zugriff: 26.06.2013
• 11 European medicines agency. European Medicines Agency recommends approval of first vaccine for meningitis B [Internet]. Available from: 2012. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/11/news_detail_001656.jsp&mid=WC0b01ac058004d5c1 Letzter Zugriff: 26.6.2013
• 12 Gaston MH, Verter JI, Woods G et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986; 314: 1593-1599
• 13 Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001; 4: 105-121
• 14 Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78: 1031-1038
• 15 Joseph JT, Roy SS, Shams N et al. Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis 2011; 17: 843-847
• 16 Kang Y-S, Do Y, Lee H-K et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 2006; 125: 47-58
• 17 King H, Shumaker HB. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg 1952; 136: 239-242
• 18 Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596
• 19 Kyaw MH, Holmes EM, Toolis F et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 119: 276.e1-7
• 20 Lammers AJ, de Porto AP, Florquin S et al. Enhanced vulnerability for Streptococcus pneumoniae sepsis during asplenia is determined by the bacterial capsule. Immunobiology 2011; 216: 863-870
• 21 Lee LH, Frasch CE, Falk LA et al. Correlates of immunity for pneumococcal conjugate vaccines. Vaccine 2003; 21: 2190-2196
• 22 Mahlaoui N, Minard-Colin V, Picard C et al. Isolated congenital asplenia: a French nationwide retrospective survey of 20 cases. J Pediatr 2011; 158: 142-148
• 23 Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5: 606-616
• 24 Mühlemann K. Prävention schwerer Infektionen bei anatomischer oder funktioneller Asplenie. Bull BAG 2006; 49: 977-983
• 25 Musher DM, Sampath R, Rodriguez-Barradas MC. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?. Clin Infect Dis 2011; 52: 633-640
• 26 Pers C, Gahrn-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin Infect Dis 1996; 23: 71-75
• 27 Rehnberg M, Amu S, Tarkowski A et al. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther 2009; 11: R123
• 28 Rehnberg M, Brisslert M, Amu S et al. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment. Arthritis Res Ther 2010; 12: R111
• 29 Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines-an unfinished story. Lancet Infect Dis 2010; 10: 112-124
• 30 Schwartz PE, Sterioff S, Mucha P et al. Postsplenectomy sepsis and mortality in adults. JAMA 1982; 248: 2279-2283
• 31 Shatz DV, Schinsky MF, Pais LB et al. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998; 44: 760-765
• 32 Thomsen RW, Schoonen WM, Farkas DK et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med 2009; 151: 546-555
• 33 Van Der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-1556
• 34 Vesikari T, Esposito S, Prymula R et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013; 381: 825-835
• 35 Weinberger DM, Harboe ZB, Sanders EAM et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51: 692-699
• 36 Robert Koch-Institut. Impfungen bei Asplenie (Entfernung der Milz oder Ausfall der Organfunktion). http://www.rki.de/SharedDocs/FAQ/Impfen/AllgFr_ImpfGesundheitsschaden/FAQ01.html . Letzter Zugriff: 3.7.2013